Stock listing

OTC:GNVR Genvor Incorporated Stock

Follow Genvor Incorporated into a list and get an email when it puts out news.

Share price · OTC:GNVR

$0.90 USD 0.00 (0.0%)

Close on Oct 14, 2026 · Data provided by Twelve Data

Genvor Incorporated logo
Ticker
OTC:GNVR
Asset type
Stock
Exchange
OTC
Currency
USD

What changed lately

Latest news

Genvor’s Antimicrobial Peptides Advance into Sugar Beet Research

Jul 27, 2026

Genvor Appoints Donald Kalkofen as Chief Financial Officer

May 21, 2026

Genvor Announces Strategic Memorandum of Understanding with Canlab International(TM) to Advance Peptide Pipeline

Apr 17, 2026

Genvor Announces Strategic Memorandum of Understanding with Canlab International™ to Advance Commercial Peptide Pipeline

Apr 14, 2026

Genvor to Present at Centri Capital Conference on April 14

Apr 7, 2026

Genvor, Inc. Presenting at NIBA's 152nd Investment Conference in Fort Lauderdale, FL March 12, 2026

Mar 5, 2026

Genvor Announces Strategic Expansion into Health and Wellness Market, Leveraging Proprietary AI-Accelerated BioCypher Platform to Develop Consumer Peptide Solutions

Mar 4, 2026

Genvor’s AGM182 Antifungal Peptide Technology Validated in Peer-Reviewed Publication in PhytoFrontiers™

Feb 11, 2026

Genvor Appoints Dr. George Stavrides as Executive Vice President, Business Development & Commercialization

Jan 28, 2026

DealFlow Discovery Conference Announces Initial Lineup of Presenting Companies Ahead of Next Week's Event

Jan 23, 2026

Issued by another party

All Genvor Incorporated news

Decks

Genvor Incorporated on 6ix

News releases
16 in the last 12 months · 27 in all · newest Jul 27, 2026 · oldest 2023
Decks
1 deck · latest March 2026

Log in to ask 6ix AI your own questions about Genvor Incorporated.